Navigation Links
EMD Serono, Inc. Announces Expansion with Research Site in Cambridge, Massachusetts
Date:3/30/2009

ng plans still on track."

In 2008, EMD Serono announced a planned expansion of its Billerica laboratory to create a center of excellence in discovery, which is scheduled for completion in 2010. The Cambridge satellite laboratory, which will be approximately 18,000 square feet in size, will address the company's immediate need to secure necessary laboratory space for its additional scientists as a result of accelerated employee growth.

EMD Serono completed the first Phase III trial of an oral multiple sclerosis drug, cladribine, which is targeted for registration filing later this year. With these additional capabilities the company plans to focus research and development efforts towards Parkinson's disease, and other neurodegenerative diseases.

About EMD Serono, Inc.

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives.

The company has strong market positions in neurodegenerative diseases, with Rebif(R) (interferon beta-1a), as well as in endocrinology, with Saizen(R) (somatropin (rDNA origin) for injection) and Serostim(R) (somatropin (rDNA origin) for injection). EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) Prefilled Syringe (choriogonadotropin alfa injection). With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono's US footprint continues to grow, with more than 1000 employees around the country and fully integrated commercial, clinical and research operations in the company's home state of Massachusetts.

For more information, please visit www.emdserono.com

'/>"/>

SOURCE EMD Serono, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders
2. iMedica Corporation Announces the Release of Patient Relationship Manager 2009
3. Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints
4. LCA-Vision Announces Termination of Consent Solicitation and Withdrawal of Dissident Slate of Director Nominees
5. Thomson Reuters Announces 100 Top Hospitals Award Winners
6. iMedica Corporation Announces Release of Patient Relationship Manager 2009
7. KMSI Announces KMx Update That Provides eLearning, Knowledge Management and Collaboration Tools for Apple iPhone and Other Mobile Devices
8. Academy of Lymphatic Studies Announces Accelerated Hybrid Online Program
9. Human Pheromone Sciences Announces Fourth Quarter and Full Year Results
10. Nationwide Medical/Surgical Announces Availability of Tamiflu for the 2009-2010 Influenza Season
11. Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Jupiter Medical Center and The Mount ... Heart New York at Jupiter Medical Center, to enhance ... , “This innovative collaboration with Mount Sinai Heart ... health care in our very own backyard,” said John ... Medical Center. “This kind of innovative thinking will transform ...
(Date:2/27/2015)... York, NY (PRWEB) February 27, 2015 Over ... medical harm. The time is now to educate readers on ... their condition. This campaign will serve as a guide to ... can keep themselves and their loved ones safe with tips ... Dr. Richard Carmona graces the cover of the print publication. ...
(Date:2/27/2015)... According to the report, the annual revenue ... in 2013 rose by 31.9%. However, in the first ... generated by the industry was recorded at RMB3.623 billion ... industry in 2013. , View Full Report at ... oral industry as a branch of medical industry that ...
(Date:2/27/2015)... 27, 2015 BaliniSports is expanding its ... online fitness social platform FITMOO. The collaboration is aimed ... holistic philosophy behind BaliniSports. Users of FITMOO will be ... way and discover apparel that will enhance their workouts. ... environmentally friendly and socially conscious methods to produce its ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Cocaine is ... to experience intense depression and hostility. In a joint ... and specifically addicts of cocaine, may soon rejoice in ... to negate the addictive biological response of cocaine, according ... to the article, researchers discovered that the brain is ...
Breaking Medicine News(10 mins):Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5Health News:Safe and Sound: Improving Patient Outcomes through Mediaplanet’s “Patient Safety” Campaign 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:BaliniSports Announces Collaboration with FITMOO 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 3
... MADISON -- The National Institutes of Health (NIH) has awarded ... Research (ICTR) one of the largest grants in the history ... UW-Madison a key player in an ambitious NIH plan to ... The primary goal of the plan is to find ways ...
... EVANSTON, Ill., Sept. 18 American Board of,Medical ... physician specialists in the United States, announced at,its ... Directors has,appointed Kevin B. Weiss, MD, MPH, as ... will take up his new duties Dec. 17, ...
... growth and steady ... decades, GLEN BURNIE, Md., Sept. 18 After 38 ... and CEO,James R. Walker has announced his intention to retire ... BWMC Board of Directors meeting. (Photo: http://www.newscom.com/cgi-bin/prnh/20070918/DCTU027 ...
... leave,benefits for military families is a desirable and ... the needs of employees and employers, according,to the ... largest,association of human resource professionals., As Congress ... of the,National Guard, Reservists and their families, underlying ...
... Sept. 18 The,National Quality Forum (NQF) and The Joint ... Eisenberg Patient Safety and Quality,Awards. Honorees were selected in all ... as follows:, INDIVIDUAL ACHIEVEMENT (2 RECIPIENTS), -- Flaura ... Prevention at The Children,s Hospital of ...
... When it is quiet almost too quiet in ... wrong for the good guys. This holds true for the genes ... Toledo in Toledo, Ohio, have learned. They identified a panel of ... their collective activity becomes quiet almost too quiet -- it ...
Cached Medicine News:Health News:Major grant advances UW's clinical and translational research enterprise 2Health News:Major grant advances UW's clinical and translational research enterprise 3Health News:ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO 2Health News:ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO 3Health News:BWMC President and CEO Announces Retirement 2Health News:BWMC President and CEO Announces Retirement 3Health News:SHRM Testimony Urges Congress to Fix FMLA 2Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 2Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 3Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 4Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 5Health News:Test for lung cancer looks for discomforting quiet among protective genes 2Health News:Test for lung cancer looks for discomforting quiet among protective genes 3
(Date:2/27/2015)... KING OF PRUSSIA, Pa. , Feb. 27, 2015 ... part of its ongoing commitment to the global bleeding ... it is donating 2 million international units (IUs) of ... WFH is an international not-for- profit organization which has ... and other inherited bleeding disorders. The donation supports the ...
(Date:2/27/2015)... Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the fourth quarter and full ... was a transformative year for PTC. We are now ... developing RNA-targeted therapies in the rare disease space," stated ... Inc. "We are proud to bring the first treatment ...
(Date:2/27/2015)... 2015 ... kongestive Herzinsuffizienz (CHF) in seiner ersten klinischen ...   Die israelische Firma ... für Patienten mit kongestiver Herzinsuffizienz (CHF) entwickelt ... Finanzierungsvorhaben über 5 Mio. USD abgeschlossen hat. ...
Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... March 21, 2012 Roka Bioscience announced today that ... Performance Tested Methods(SM) certification from the AOAC Research ... Silliker, Inc., as part of the AOAC-RI independent third-party ... runs on the Atlas System, an innovative fully automated ...
... 21, 2012  Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Phase 1 clinical program with their investigational product ... targeting PCSK9 (proprotein convertase subtilisin/kexin type 9 serine ... issue of the New England Journal of ...
Cached Medicine Technology:Roka Bioscience Awarded AOAC-RI Certification for Atlas™ Salmonella Detection Assay 2Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 2Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 3Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 4
... CTi Wrist is a custom wrist orthotic designed to ... patient's maximum range-of-motion. , ,Indications: , Wrist ... fibrocartilage complex , Coles fracture - distal ... Partial tendon rupture , ORIF - Open ...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Provides secure fracture immobilization while allowing for full range of motion at elbow and wrist...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: